Short answer · Medically reviewed summary · Last updated: 2026-04-08
Retinitis pigmentosa is a group of rare, inherited genetic disorders that cause the progressive loss of photoreceptor cells in the retina, affecting approximately 1 in 3,000 to 1 in 4,000 individuals worldwide. While considered a rare disease, the prevalence varies significantly based on genetic background and geographic location, often leading to underdiagnosis due to the broad spectrum of clinical presentations. What is the global prevalence and incidence of Retinitis pigmentosa? Retinitis pigmentosa is categorized as a rare disease.
2 people with Retinitis pigmentosa have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of Retinitis pigmentosa?
Prevalence of Retinitis pigmentosa: how many people are affected worldwide, differences by sex and region, with sources.
Retinitis pigmentosa is a group of rare, inherited genetic disorders that cause the progressive loss of photoreceptor cells in the retina, affecting approximately 1 in 3,000 to 1 in 4,000 individuals worldwide. While considered a rare disease, the prevalence varies significantly based on genetic background and geographic location, often leading to underdiagnosis due to the broad spectrum of clinical presentations.
What is the global prevalence and incidence of Retinitis pigmentosa?
Retinitis pigmentosa is categorized as a rare disease. According to data from Orphanet and the NIH Genetic and Rare Diseases Information Center (GARD), the global prevalence is estimated to be between 1 in 3,000 and 1 in 4,000 people. Because Retinitis pigmentosa is a chronic, progressive condition rather than an acute event, "incidence" is often measured by the rate of new genetic diagnoses. It is important to note that these figures are estimates; true prevalence is likely higher, as many individuals with milder or late-onset forms of Retinitis pigmentosa may remain undiagnosed or misdiagnosed for years.
Does Retinitis pigmentosa affect genders and age groups differently?
The clinical expression and inheritance of Retinitis pigmentosa can vary by gender, depending on the specific genetic mutation involved. While autosomal recessive and autosomal dominant forms affect males and females equally, X-linked Retinitis pigmentosa primarily affects males, who often experience more severe and earlier-onset symptoms. Regarding age of onset, Retinitis pigmentosa is typically characterized by adolescent or young adult onset, though it can manifest in early childhood or not until middle age. The DiseaseMaps.org community, which currently includes 707 people living with Retinitis pigmentosa, reflects this wide variance in diagnostic age and the diverse experiences of patients navigating the progression of their condition.
Are there geographic or ethnic variations in Retinitis pigmentosa?
Genetic diversity plays a significant role in the prevalence of this condition. In certain populations, such as in parts of Ireland, Norway, and among the Navajo people in the United States, the prevalence of Retinitis pigmentosa is notably higher than the global average due to founder effects—where a specific genetic mutation becomes more common within an isolated population. Because Retinitis pigmentosa is caused by mutations in over 100 different genes, the specific burden of the disease within any given community is heavily dependent on the local genetic landscape.
Why is accurate data on Retinitis pigmentosa prevalence difficult to obtain?
Tracking the exact number of people with Retinitis pigmentosa is challenging for several clinical and structural reasons:
- Diagnostic Complexity: The condition is highly heterogeneous, meaning different genetic mutations cause different rates of vision loss, often leading to initial misdiagnosis as other retinal dystrophies.
- Variable Expressivity: Family members with the same genetic mutation may experience symptoms with varying levels of severity, causing some to go uncounted in clinical registries.
- Limited Genetic Testing: In many parts of the world, access to the genetic counseling and molecular testing required to confirm a diagnosis of Retinitis pigmentosa is not standardized.
- Patient Reporting: Because the condition is progressive, individuals may not seek medical attention until symptoms are advanced, delaying their entry into epidemiological databases.
Next steps
- Consult with a retina specialist or an ophthalmogeneticist to discuss genetic testing options for Retinitis pigmentosa.
- Connect with the 707 members of the DiseaseMaps.org community to share experiences and learn about regional resources.
- Register with patient advocacy groups like the Foundation Fighting Blindness to stay informed about the latest clinical trials and therapeutic breakthroughs.
- Ensure your records are shared with national rare disease registries to help improve the accuracy of future prevalence data.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- Orphanet: Retinitis pigmentosa (ORPHA:791)
- NIH Genetic and Rare Diseases Information Center (GARD): Retinitis pigmentosa
- OMIM (Online Mendelian Inheritance in Man): Retinitis pigmentosa overview
- Foundation Fighting Blindness: Understanding Retinitis pigmentosa
Autosomal dominant and recessive forms of Retinitis Pigmentosa affect both male and female populations equally; however, the less frequent X-linked form of the disease affects male recipients of the X-linked mutation, while females usually remain unaffected carriers of the RP trait. The X-linked forms of the disease are considered severe, and typically lead to complete blindness during later stages. In rare occasions, a dominant form of the X-linked gene mutation will affect both males and females equally.
Due to the genetic inheritance patterns of RP, many isolate populations exhibit higher disease frequencies or increased prevalence of a specific RP mutation. Pre-existing or emerging mutations that contribute to rod photoreceptor degeneration in Retinitis Pigmentosa are passed down through familial lines; thus, allowing certain RP cases to be concentrated to specific geographical regions with an ancestral history of the disease. Several hereditary studies have been performed to determine the varying prevalence rates in Maine (USA), Birmingham (England), Switzerland (affects 1/7000), Denmark (affects 1/2500), and Norway. Navajo Indians display an elevated rate of RP inheritance as well, which is estimated as affecting 1 in 1878 individuals. Despite the increased frequency of RP within specific familial lines, the disease is considered non-discriminatory and tends to equally affect all world populations.
Posted Jul 24, 2017 by Filip 2150
Posted Jan 13, 2018 by Anders 2500
